{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T21:32:45Z","timestamp":1791840765695,"version":"4.3.4"},"reference-count":95,"publisher":"Elsevier","isbn-type":[{"value":"9780128126035","type":"print"}],"license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017]]},"DOI":"10.1016\/bs.irn.2017.04.009","type":"book-chapter","created":{"date-parts":[[2017,6,2]],"date-time":"2017-06-02T13:16:44Z","timestamp":1496409404000},"page":"1409-1441","source":"Crossref","is-referenced-by-count":68,"title":["Nonmotor Symptoms in Amyotrophic Lateral Sclerosis: A Systematic Review"],"prefix":"10.1016","author":[{"given":"Ton","family":"Fang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Jozsa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ammar","family":"Al-Chalabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Pt. 6","key":"10.1016\/bs.irn.2017.04.009_bb0005","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1093\/brain\/119.6.2105","article-title":"Frontal lobe dysfunction in amyotrophic lateral sclerosis. A PET study","volume":"119","author":"Abrahams","year":"1996","journal-title":"Brain"},{"issue":"1\u20132","key":"10.1016\/bs.irn.2017.04.009_bb0010","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3109\/21678421.2013.805784","article-title":"Screening for cognition and behaviour changes in ALS","volume":"15","author":"Abrahams","year":"2014","journal-title":"Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration"},{"issue":"4","key":"10.1016\/bs.irn.2017.04.009_bb0015","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1163\/15685690260494924","article-title":"Effect of exercise therapy on pain complaints in patients with amyotrophic lateral sclerosis","volume":"14","author":"Aksu","year":"2002","journal-title":"The Pain Clinic"},{"issue":"3","key":"10.1016\/bs.irn.2017.04.009_bb0020","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.ijrobp.2013.11.230","article-title":"Radiation therapy for hypersalivation: A prospective study in 50 amyotrophic lateral sclerosis patients","volume":"88","author":"Assouline","year":"2014","journal-title":"International Journal of Radiation Oncology Biology Physics"},{"issue":"2","key":"10.1016\/bs.irn.2017.04.009_bb0025","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3109\/17482968.2010.536839","article-title":"Depression in amyotrophic lateral sclerosis","volume":"12","author":"Atassi","year":"2011","journal-title":"Amyotrophic Lateral Sclerosis"},{"issue":"7454","key":"10.1016\/bs.irn.2017.04.009_bb0030","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","article-title":"Grading quality of evidence and strength of recommendations","volume":"328","author":"Atkins","year":"2004","journal-title":"BMJ"},{"issue":"3\u20134","key":"10.1016\/bs.irn.2017.04.009_bb0035","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3109\/21678421.2014.897357","article-title":"Estimating clinical stage of amyotrophic lateral sclerosis from the ALS functional rating scale","volume":"15","author":"Balendra","year":"2014","journal-title":"Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration"},{"issue":"2","key":"10.1016\/bs.irn.2017.04.009_bb0040","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1080\/14660820510028412","article-title":"Autonomic dysfunction in ALS: A preliminary study on the effects of intrathecal BDNF","volume":"6","author":"Beck","year":"2005","journal-title":"Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders"},{"key":"10.1016\/bs.irn.2017.04.009_bb0045","series-title":"Cognitive-behavioral changes in amyotrophic lateral sclerosis: Prevalence, progression, and impact on patients and caregivers","author":"Bock","year":"2015"},{"issue":"3","key":"10.1016\/bs.irn.2017.04.009_bb0050","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1080\/146608201753275517","article-title":"Standards of palliative care for patients with amyotrophic lateral sclerosis: Results of a European survey","volume":"2","author":"Borasio","year":"2001","journal-title":"Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders"},{"issue":"3","key":"10.1016\/bs.irn.2017.04.009_bb0055","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.canrad.2013.01.010","article-title":"Salivary glands radiotherapy to reduce sialorrhea in amyotrophic lateral sclerosis: Dose and energy","volume":"17","author":"Bourry","year":"2013","journal-title":"Cancer\/Radiotherapie"},{"key":"10.1016\/bs.irn.2017.04.009_bb0060","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/1741-7015-9-90","article-title":"Cross-national epidemiology of DSM-IV major depressive episode","volume":"9","author":"Bromet","year":"2011","journal-title":"BMC Medicine"},{"issue":"8","key":"10.1016\/bs.irn.2017.04.009_bb0065","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1212\/01.WNL.0000142042.50528.2F","article-title":"Treatment of pseudobulbar affect in ALS with dextromethorphan\/quinidine: A randomized trial","volume":"63","author":"Brooks","year":"2004","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/bs.irn.2017.04.009_bb0070","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nrm2873","article-title":"Prion-like transmission of protein aggregates in neurodegenerative diseases","volume":"11","author":"Brundin","year":"2010","journal-title":"Nature Reviews. Molecular Cell Biology"},{"issue":"1\u20132","key":"10.1016\/bs.irn.2017.04.009_bb0075","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0022-510X(99)00210-5","article-title":"The ALSFRS-R: A revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III)","volume":"169","author":"Cedarbaum","year":"1999","journal-title":"Journal of the Neurological Sciences"},{"issue":"3","key":"10.1016\/bs.irn.2017.04.009_bb0080","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1474-4422(06)70373-8","article-title":"Non-motor symptoms of Parkinson's disease: Diagnosis and management","volume":"5","author":"Chaudhuri","year":"2006","journal-title":"Lancet Neurology"},{"issue":"7","key":"10.1016\/bs.irn.2017.04.009_bb0085","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1002\/mds.20844","article-title":"International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson's disease: The NMSQuest study","volume":"21","author":"Chaudhuri","year":"2006","journal-title":"Movement Disorders"},{"issue":"4","key":"10.1016\/bs.irn.2017.04.009_bb0090","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/j.1468-1331.2011.03540.x","article-title":"Pain in amyotrophic lateral sclerosis: A population-based controlled study","volume":"19","author":"Chio","year":"2012","journal-title":"European Journal of Neurology"},{"issue":"5\u20136","key":"10.1016\/bs.irn.2017.04.009_bb0095","doi-asserted-by":"crossref","first-page":"310","DOI":"10.3109\/17482960802566824","article-title":"Prognostic factors in ALS: A critical review","volume":"10","author":"Chio","year":"2009","journal-title":"Amyotrophic Lateral Sclerosis"},{"key":"10.1016\/bs.irn.2017.04.009_bb0100","author":"Cleeland"},{"issue":"5","key":"10.1016\/bs.irn.2017.04.009_bb0105","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1468-1331.2008.02102.x","article-title":"Morphine in the management of dyspnoea in ALS. A pilot study","volume":"15","author":"Clemens","year":"2008","journal-title":"European Journal of Neurology"},{"issue":"3","key":"10.1016\/bs.irn.2017.04.009_bb0110","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1177\/026921639500900306","article-title":"The McGill quality of life questionnaire: A measure of quality of life appropriate for people with advanced disease. A preliminary study of validity and acceptability","volume":"9","author":"Cohen","year":"1995","journal-title":"Palliative Medicine"},{"issue":"4","key":"10.1016\/bs.irn.2017.04.009_bb0115","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s00415-008-0738-5","article-title":"Botulinum toxin type-B improves sialorrhea and quality of life in bulbaronset amyotrophic lateral sclerosis","volume":"255","author":"Costa","year":"2008","journal-title":"Journal of Neurology"},{"issue":"13","key":"10.1016\/bs.irn.2017.04.009_bb0120","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1212\/01.wnl.0000285080.70324.27","article-title":"Dyslipidemia is a protective factor in amyotrophic lateral sclerosis","volume":"70","author":"Dupuis","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/bs.irn.2017.04.009_bb0125","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1080\/21678421.2016.1265565","article-title":"Comparison of the King's and MiToS staging systems for ALS","volume":"18","author":"Fang","year":"2017","journal-title":"Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration"},{"key":"10.1016\/bs.irn.2017.04.009_bb0130","author":"Fang"},{"issue":"Pt. 10","key":"10.1016\/bs.irn.2017.04.009_bb0135","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1093\/brain\/awn161","article-title":"Suicide among patients with amyotrophic lateral sclerosis","volume":"131","author":"Fang","year":"2008","journal-title":"Brain"},{"issue":"4","key":"10.1016\/bs.irn.2017.04.009_bb0140","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3109\/17482968.2011.556744","article-title":"Prevalence of major depression in ALS: Comparison of a semi-structured interview and four self-report measures","volume":"12","author":"Ferentinos","year":"2011","journal-title":"Amyotrophic Lateral Sclerosis"},{"issue":"14","key":"10.1016\/bs.irn.2017.04.009_bb0145","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1212\/WNL.0b013e3181f61311","article-title":"What predicts mortality in Parkinson disease? A prospective population-based long-term study","volume":"75","author":"Forsaa","year":"2010","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/bs.irn.2017.04.009_bb0150","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3109\/17482960903264998","article-title":"Botulinum toxin type a for the treatment of sialorrhoea in amyotrophic lateral sclerosis: A clinical and neurophysiological study","volume":"11","author":"Gilio","year":"2010","journal-title":"Amyotrophic Lateral Sclerosis"},{"key":"10.1016\/bs.irn.2017.04.009_bb0155","first-page":"90","article-title":"Stroop color and word test","volume":"15","author":"Golden","year":"1978","journal-title":"Age"},{"issue":"5\u20136","key":"10.1016\/bs.irn.2017.04.009_bb0160","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3109\/21678421.2015.1062515","article-title":"Psychotherapy and pharmacotherapy interventions to reduce distress or improve well-being in people with amyotrophic lateral sclerosis: A systematic review","volume":"16","author":"Gould","year":"2015","journal-title":"Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration"},{"issue":"2","key":"10.1016\/bs.irn.2017.04.009_bb0165","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/mds.23473","article-title":"Botulinum toxin a versus B in Sialorrhea: A prospective, randomized, double-blind, crossover pilot study in patients with amyotrophic lateral sclerosis or Parkinson's disease","volume":"26","author":"Guidubaldi","year":"2011","journal-title":"Movement Disorders"},{"key":"10.1016\/bs.irn.2017.04.009_bb0170","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3389\/fneur.2016.00117","article-title":"Non-motor symptoms in patients suffering from motor neuron diseases","volume":"7","author":"Gunther","year":"2016","journal-title":"Frontiers in Neurology"},{"issue":"1\u20132","key":"10.1016\/bs.irn.2017.04.009_bb0175","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jad.2007.11.012","article-title":"Validity of the ALS-Depression-Inventory (ADI-12)\u2014A new screening instrument for depressive disorders in patients with amyotrophic lateral sclerosis","volume":"109","author":"Hammer","year":"2008","journal-title":"Journal of Affective Disorders"},{"issue":"3","key":"10.1016\/bs.irn.2017.04.009_bb0180","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/brb3.296","article-title":"Characteristics of pain in amyotrophic lateral sclerosis","volume":"5","author":"Hanisch","year":"2015","journal-title":"Brain and Behavior"},{"issue":"10","key":"10.1016\/bs.irn.2017.04.009_bb0185","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1001\/archpsyc.62.10.1097","article-title":"Epidemiology of major depressive disorder: Results from the National Epidemiologic Survey on Alcoholism and Related Conditions","volume":"62","author":"Hasin","year":"2005","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/bs.irn.2017.04.009_bb0190","series-title":"Beck depressions-inventar (BDI-II)","author":"Hautzinger","year":"2006"},{"issue":"5","key":"10.1016\/bs.irn.2017.04.009_bb0195","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1080\/17482960701538825","article-title":"Pressure ulcers in ALS patients on admission at a university hospital in Japan","volume":"8","author":"Hayashi","year":"2007","journal-title":"Amyotrophic Lateral Sclerosis"},{"key":"10.1016\/bs.irn.2017.04.009_bb0200","series-title":"Wisconsin card sorting test: Psychological assessment resources","author":"Heaton","year":"1993"},{"issue":"1","key":"10.1016\/bs.irn.2017.04.009_bb0205","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/CND.0b013e31821c5623","article-title":"Shoulder pain in amyotrophic lateral sclerosis","volume":"13","author":"Ho","year":"2011","journal-title":"Journal of Clinical Neuromuscular Disease"},{"issue":"2","key":"10.1016\/bs.irn.2017.04.009_bb0210","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/mus.21213","article-title":"Randomized double-blind study of botulinum toxin type B for sialorrhea in ALS patients","volume":"39","author":"Jackson","year":"2009","journal-title":"Muscle and Nerve"},{"issue":"6","key":"10.1016\/bs.irn.2017.04.009_bb0215","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/sleep\/14.6.540","article-title":"A new method for measuring daytime sleepiness: The Epworth sleepiness scale","volume":"14","author":"Johns","year":"1991","journal-title":"Sleep"},{"issue":"3\u20134","key":"10.1016\/bs.irn.2017.04.009_bb0220","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3109\/21678421.2013.872149","article-title":"Health utility decreases with increasing clinical stage in amyotrophic lateral sclerosis","volume":"15","author":"Jones","year":"2014","journal-title":"Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration"},{"issue":"1","key":"10.1016\/bs.irn.2017.04.009_bb0225","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1093\/ajcn\/63.1.130","article-title":"Nutritional status of patients with amyotrophic lateral sclerosis: Relation to the proximity of death","volume":"63","author":"Kasarskis","year":"1996","journal-title":"The American Journal of Clinical Nutrition"},{"issue":"4","key":"10.1016\/bs.irn.2017.04.009_bb0230","doi-asserted-by":"crossref","first-page":"345","DOI":"10.5664\/jcsm.2586","article-title":"Effects of noninvasive ventilation on sleep outcomes in amyotrophic lateral sclerosis","volume":"9","author":"Katzberg","year":"2013","journal-title":"Journal of Clinical Sleep Medicine"},{"issue":"23","key":"10.1016\/bs.irn.2017.04.009_bb0235","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1001\/jama.289.23.3095","article-title":"The epidemiology of major depressive disorder: Results from the National Comorbidity Survey Replication (NCS-R)","volume":"289","author":"Kessler","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/bs.irn.2017.04.009_bb0240","doi-asserted-by":"crossref","first-page":"822","DOI":"10.3389\/fpsyg.2015.00822","article-title":"Hypnosis-based psychodynamic treatment in ALS: A longitudinal study on patients and their caregivers","volume":"6","author":"Kleinbub","year":"2015","journal-title":"Frontiers in Psychology"},{"issue":"12","key":"10.1016\/bs.irn.2017.04.009_bb0245","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1136\/jnnp-2015-312908","article-title":"A clinical tool for predicting survival in ALS","volume":"87","author":"Knibb","year":"2016","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"key":"10.1016\/bs.irn.2017.04.009_bb0250","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/1471-2377-13-84","article-title":"Weight loss, dysphagia and supplement intake in patients with amyotrophic lateral sclerosis (ALS): Impact on quality of life and therapeutic options","volume":"13","author":"Koerner","year":"2013","journal-title":"BMC Neurology"},{"issue":"1","key":"10.1016\/bs.irn.2017.04.009_bb0255","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3109\/17482968.2012.692382","article-title":"Speech therapy and communication device: Impact on quality of life and mood in patients with amyotrophic lateral sclerosis","volume":"14","author":"Korner","year":"2013","journal-title":"Amyotrophic Lateral sclerosis & Frontotemporal Degeneration"},{"issue":"10","key":"10.1016\/bs.irn.2017.04.009_bb0260","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1001\/archneur.1989.00520460115022","article-title":"The fatigue severity scale: Application to patients with multiple sclerosis and systemic lupus erythematosus","volume":"46","author":"Krupp","year":"1989","journal-title":"Archives of Neurology"},{"key":"10.1016\/bs.irn.2017.04.009_bb0265","doi-asserted-by":"crossref","first-page":"b2700","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: Explanation and elaboration","volume":"339","author":"Liberati","year":"2009","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/bs.irn.2017.04.009_bb0270","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1212\/WNL.57.1.153","article-title":"A prospective study of quality of life in ALS patients treated with noninvasive ventilation","volume":"57","author":"Lyall","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/bs.irn.2017.04.009_bb0275","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2174\/1874205X01610010059","article-title":"Osteopathic manual treatment for amyotrophic lateral sclerosis: A feasibility pilot study","volume":"10","author":"Maggiani","year":"2016","journal-title":"The Open Neurology Journal"},{"issue":"11","key":"10.1016\/bs.irn.2017.04.009_bb0280","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1002\/mds.21586","article-title":"Prevalence of nonmotor symptoms in Parkinson's disease in an international setting; study using nonmotor symptoms questionnaire in 545 patients","volume":"22","author":"Martinez-Martin","year":"2007","journal-title":"Movement Disorders"},{"issue":"5","key":"10.1016\/bs.irn.2017.04.009_bb0285","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1136\/jnnp.61.5.450","article-title":"Prevalence and correlates of neuropsychological deficits in amyotrophic lateral sclerosis","volume":"61","author":"Massman","year":"1996","journal-title":"Journal of Neurology, Neurosurgery & Psychiatry"},{"issue":"3","key":"10.1016\/bs.irn.2017.04.009_bb0290","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/mus.20900","article-title":"Intrathecal baclofen for spasticity-related pain in amyotrophic lateral sclerosis: Efficacy and factors associated with pain relief","volume":"37","author":"McClelland","year":"2008","journal-title":"Muscle & Nerve"},{"issue":"10","key":"10.1016\/bs.irn.2017.04.009_bb0295","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1136\/jnnp.2008.163246","article-title":"Prevalence of fatigue and depression in ALS patients and change over time","volume":"80","author":"McElhiney","year":"2009","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"key":"10.1016\/bs.irn.2017.04.009_bb0300","doi-asserted-by":"crossref","first-page":"c869","DOI":"10.1136\/bmj.c869","article-title":"CONSORT 2010 explanation and elaboration: Updated guidelines for reporting parallel group randomised trials","volume":"340","author":"Moher","year":"2010","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/bs.irn.2017.04.009_bb0305","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1177\/0269216315600332","article-title":"Is there pain with neuropathic characteristics in patients with amyotrophic lateral sclerosis? A cross-sectional study","volume":"30","author":"Moisset","year":"2015","journal-title":"Palliative Medicine"},{"issue":"2","key":"10.1016\/bs.irn.2017.04.009_bb0310","doi-asserted-by":"crossref","first-page":"194","DOI":"10.3109\/17482968.2011.610110","article-title":"Modifying effect of arterial hypertension on amyotrophic lateral sclerosis","volume":"13","author":"Moreau","year":"2012","journal-title":"Amyotrophic Lateral Sclerosis"},{"issue":"4","key":"10.1016\/bs.irn.2017.04.009_bb0315","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1089\/jpm.2004.7.551","article-title":"Individual quality of life is not correlated with health-related quality of life or physical function in patients with amyotrophic lateral sclerosis","volume":"7","author":"Neudert","year":"2004","journal-title":"Journal of Palliative Medicine"},{"issue":"6","key":"10.1016\/bs.irn.2017.04.009_bb0320","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/clpt.1993.206","article-title":"Trial of oral physostigmine in amyotrophic lateral sclerosis","volume":"54","author":"Norris","year":"1993","journal-title":"Clinical Pharmacology & Therapeutics"},{"issue":"3\u20134","key":"10.1016\/bs.irn.2017.04.009_bb0325","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3109\/21678421.2013.868001","article-title":"Increased prevalence of bladder and intestinal dysfunction in amyotrophic lateral sclerosis","volume":"15","author":"Nuebling","year":"2014","journal-title":"Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration"},{"issue":"4","key":"10.1016\/bs.irn.2017.04.009_bb0330","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.clinph.2009.01.013","article-title":"Cognitive deficits in amyotrophic lateral sclerosis evaluated by event-related potentials","volume":"120","author":"Ogawa","year":"2009","journal-title":"Clinical Neurophysiology"},{"issue":"5","key":"10.1016\/bs.irn.2017.04.009_bb0335","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1080\/08870446.2014.982652","article-title":"Mindfulness, physical impairment and psychological well-being in people with amyotrophic lateral sclerosis","volume":"30","author":"Pagnini","year":"2015","journal-title":"Psychology & Health"},{"issue":"5","key":"10.1016\/bs.irn.2017.04.009_bb0340","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/ana.20828","article-title":"Randomized, controlled trial of dextromethorphan\/quinidine for pseudobulbar affect in multiple sclerosis","volume":"59","author":"Panitch","year":"2006","journal-title":"Annals of Neurology"},{"issue":"1","key":"10.1016\/bs.irn.2017.04.009_bb0345","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000097849","article-title":"Affective disorders in motor neuron disease: A population-based study","volume":"28","author":"Patten","year":"2007","journal-title":"Neuroepidemiology"},{"issue":"2","key":"10.1016\/bs.irn.2017.04.009_bb0350","first-page":"115","article-title":"Depression, pain and quality of life in patients with amyotrophic lateral sclerosis: A cross-sectional study","volume":"28","author":"Pizzimenti","year":"2013","journal-title":"Functional Neurology"},{"issue":"Suppl. 1","key":"10.1016\/bs.irn.2017.04.009_bb0355","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1468-1331.2008.02056.x","article-title":"Non-motor symptoms in Parkinson's disease","volume":"15","author":"Poewe","year":"2008","journal-title":"European Journal of Neurology"},{"issue":"1","key":"10.1016\/bs.irn.2017.04.009_bb0360","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1212\/01.wnl.0000167187.14501.0c","article-title":"Prevalence of depressive disorders and change over time in late-stage ALS","volume":"65","author":"Rabkin","year":"2005","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/bs.irn.2017.04.009_bb0365","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/mus.21245","article-title":"Modafinil treatment of fatigue in patients with ALS: A placebo-controlled study","volume":"39","author":"Rabkin","year":"2009","journal-title":"Muscle & Nerve"},{"issue":"4","key":"10.1016\/bs.irn.2017.04.009_bb0370","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/MRR.0000000000000187","article-title":"Active music therapy approach in amyotrophic lateral sclerosis: A randomized-controlled trial","volume":"39","author":"Raglio","year":"2016","journal-title":"International Journal of Rehabilitation Research"},{"issue":"4","key":"10.1016\/bs.irn.2017.04.009_bb0375","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/j.1365-277X.2010.01057.x","article-title":"Nutritional factors associated with survival following enteral tube feeding in patients with motor neurone disease","volume":"23","author":"Rio","year":"2010","journal-title":"Journal of Human Nutrition and Dietetics"},{"issue":"Pt. 3","key":"10.1016\/bs.irn.2017.04.009_bb0380","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1093\/brain\/awr351","article-title":"A proposed staging system for amyotrophic lateral sclerosis","volume":"135","author":"Roche","year":"2012","journal-title":"Brain"},{"issue":"18","key":"10.1016\/bs.irn.2017.04.009_bb0385","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1001\/jama.282.18.1737","article-title":"Validation and utility of a self-report version of PRIME-MD: The PHQ primary care study","volume":"282","author":"Spitzer","year":"1999","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/bs.irn.2017.04.009_bb0390","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jpainsymman.2008.02.006","article-title":"Systematic review of the effectiveness of botulinum toxin or radiotherapy for sialorrhea in patients with amyotrophic lateral sclerosis","volume":"37","author":"Stone","year":"2009","journal-title":"Journal of Pain and Symptom Management"},{"issue":"10","key":"10.1016\/bs.irn.2017.04.009_bb0395","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0045451","article-title":"The impact of autonomic dysfunction on survival in patients with dementia with Lewy bodies and Parkinson's disease with dementia","volume":"7","author":"Stubendorff","year":"2012","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/bs.irn.2017.04.009_bb0400","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1136\/jnnp-2014-310176","article-title":"The MITOS system predicts long-term survival in amyotrophic lateral sclerosis","volume":"86","author":"Tramacere","year":"2015","journal-title":"Journal of Neurology, Neurosurgery & Psychiatry"},{"issue":"6","key":"10.1016\/bs.irn.2017.04.009_bb9000","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1007\/s00415-014-7342-7","article-title":"Primitive reflexes in amyotrophic lateral sclerosis: Prevalence and correlates","volume":"261","author":"Tremolizzo","year":"2014","journal-title":"Journal of Neurology"},{"key":"10.1016\/bs.irn.2017.04.009_bb0405","series-title":"Visual search and attention test","author":"Trenerry","year":"1990"},{"issue":"5\u20136","key":"10.1016\/bs.irn.2017.04.009_bb0410","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3109\/21678421.2015.1038276","article-title":"Cognitive behavioural therapy and quality of life in psychologically distressed patients with amyotrophic lateral sclerosis and their caregivers: Results of a prematurely stopped randomized controlled trial","volume":"16","author":"Van Groenestijn","year":"2015","journal-title":"Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration"},{"key":"10.1016\/bs.irn.2017.04.009_bb0415","author":"Veritas-Health-Innovation"},{"issue":"1","key":"10.1016\/bs.irn.2017.04.009_bb0420","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1080\/17482960802267480","article-title":"Enteral and parenteral nutrition in the later stages of ALS: An observational study","volume":"10","author":"Verschueren","year":"2009","journal-title":"Amyotrophic Lateral Sclerosis"},{"issue":"8","key":"10.1016\/bs.irn.2017.04.009_bb0425","doi-asserted-by":"crossref","first-page":"573","DOI":"10.7326\/0003-4819-147-8-200710160-00010","article-title":"The strengthening the reporting of observational studies in epidemiology (STROBE) statement: Guidelines for reporting observational studies","volume":"147","author":"von Elm","year":"2007","journal-title":"Annals of Internal Medicine"},{"issue":"5","key":"10.1016\/bs.irn.2017.04.009_bb0430","doi-asserted-by":"crossref","first-page":"559","DOI":"10.5664\/jcsm.4704","article-title":"Noninvasive ventilation improves sleep in amyotrophic lateral sclerosis: A prospective polysomnographic study","volume":"11","author":"Vrijsen","year":"2015","journal-title":"Journal of Clinical Sleep Medicine"},{"issue":"7\u20138","key":"10.1016\/bs.irn.2017.04.009_bb0435","doi-asserted-by":"crossref","first-page":"520","DOI":"10.3109\/21678421.2014.951944","article-title":"The evaluation of pain in amyotrophic lateral sclerosis: A case controlled observational study","volume":"15","author":"Wallace","year":"2014","journal-title":"Amyotrophic Lateral sclerosis & Frontotemporal Degeneration"},{"issue":"10","key":"10.1016\/bs.irn.2017.04.009_bb0440","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1136\/jnnp.2009.200642","article-title":"Tetrahydrocannabinol (THC) for cramps in amyotrophic lateral sclerosis: A randomised, double-blind crossover trial","volume":"81","author":"Weber","year":"2010","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"issue":"3","key":"10.1016\/bs.irn.2017.04.009_bb0445","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/ane.12559","article-title":"Botulinum toxin-A injections vs radiotherapy for drooling in ALS","volume":"134","author":"Weikamp","year":"2016","journal-title":"Acta Neurologica Scandinavica"},{"issue":"16","key":"10.1016\/bs.irn.2017.04.009_bb0450","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1212\/WNL.0000000000002507","article-title":"A randomized trial of mexiletine in ALS: Safety and effects on muscle cramps and progression","volume":"86","author":"Weiss","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/bs.irn.2017.04.009_bb0455","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1750-1172-4-3","article-title":"Amyotrophic lateral sclerosis","volume":"4","author":"Wijesekera","year":"2009","journal-title":"Orphanet Journal of Rare Diseases"},{"issue":"1","key":"10.1016\/bs.irn.2017.04.009_bb0460","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1468-1331.2009.02801.x","article-title":"Frontal-lobe mediated behavioral dysfunction in amyotrophic lateral sclerosis","volume":"17","author":"Witgert","year":"2010","journal-title":"European Journal of Neurology"},{"issue":"6","key":"10.1016\/bs.irn.2017.04.009_bb0465","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","article-title":"The hospital anxiety and depression scale","volume":"67","author":"Zigmond","year":"1983","journal-title":"Acta Psychiatrica Scandinavica"},{"issue":"1","key":"10.1016\/bs.irn.2017.04.009_bb0470","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1001\/archpsyc.1965.01720310065008","article-title":"A self-rating depression scale","volume":"12","author":"Zung","year":"1965","journal-title":"Archives of General Psychiatry"}],"container-title":["International Review of Neurobiology","Nonmotor Parkinson\u2019s: The Hidden Face - Management and the Hidden Face of Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0074774217300399?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0074774217300399?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,9]],"date-time":"2020-10-09T09:11:44Z","timestamp":1602234704000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0074774217300399"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"ISBN":["9780128126035"],"references-count":95,"URL":"https:\/\/doi.org\/10.1016\/bs.irn.2017.04.009","relation":{},"ISSN":["0074-7742"],"issn-type":[{"value":"0074-7742","type":"print"}],"subject":[],"published":{"date-parts":[[2017]]}}}